Samlyn Capital’s Dentsply Sirona XRAY Stock Holding History

Samlyn Capital’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-354,871	Closed	-$22.4M	–	197
2021 Q2	$22.4M	Buy	+354,871	New	+$23.4M	0.33%	67

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Samlyn Capital's XRAY Position: Q3 2021 in Review

Samlyn Capital sold out of Dentsply Sirona (XRAY) in Q3 2021, closing a stake of 354,871 shares — an estimated $22.4M sold.

Samlyn Capital first reported a position in XRAY in Q2 2021 and held it in 1 quarter. The position peaked at $22.4M in Q2 2021. 553 funds tracked by Wall St. Rank hold XRAY as of Q3 2021.

Samlyn Capital reported no remaining Dentsply Sirona position as of Q3 2021 after selling out during the quarter.
Samlyn Capital sold 354,871 Dentsply Sirona shares in Q3 2021, an estimated $22.4M.
Samlyn Capital first reported a position in Dentsply Sirona in Q2 2021 and held it in 1 quarter.
Samlyn Capital's Dentsply Sirona position peaked at $22.4M in Q2 2021.
553 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2021.

Based on Samlyn Capital's 13F filing for Q3 2021, filed 15 Nov 2021.